Hlywd Md Science Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-01-2025
- Paid Up Capital ₹ 0.10 M
as on 16-01-2025
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -1520.42%
(FY 2023)
- Ebitda -2030.81%
(FY 2023)
- Net Worth -229.07%
(FY 2023)
- Total Assets 444.60%
(FY 2023)
About Hlywd Md Science
The Corporate was formerly known as Hlywd Md Skin Care Private Limited. The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kunal Bijlani and Harshna Bijlani serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC313764
- Company No.
313764
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Hlywd Md Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kunal Bijlani  | Director | 10-Sep-2018 | Current |
Harshna Bijlani  | Director | 10-Sep-2018 | Current |
Financial Performance of Hlywd Md Science.
Hlywd Md Science Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1520.42% decrease in profit. The company's net worth observed a substantial decline by a decrease of 229.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hlywd Md Science?
Unlock access to Hlywd Md Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Eterno Distributors Private LimitedActive 4 years 5 monthsKunal Bijlani and Harshna Bijlani are mutual person
Ageless Clinic Private LimitedActive 5 years 9 monthsKunal Bijlani and Harshna Bijlani are mutual person
- Clinineo Technology Private LimitedActive 1 year 9 months
Kunal Bijlani and Harshna Bijlani are mutual person
- Ageless Hair Studio Private LimitedActive 3 years 8 months
Kunal Bijlani and Harshna Bijlani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hlywd Md Science?
Unlock and access historical data on people associated with Hlywd Md Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hlywd Md Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hlywd Md Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
